Skip to content

Are zinc containing Rasausadhis safe?

A Comparative Pharmaceutico - analytical and Invivo Anti-diabetic Study of Yashada Bhasma prepared by two different methods

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/10/010047
Enrollment
500
Registered
2017-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Irrespective of specific disease

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients irrespective of disease, consuming Yashada Bhasma or its formulations

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To generate data pertaining to the pattern of Zinc containing formulations.Timepoint: After completion of the study.

Secondary

MeasureTime frame
To generate data pertaining to the pattern of Zinc containing formulations available in market and its practice in clinical set upTimepoint: single point

Countries

India

Contacts

Public ContactDr Himanshu Sharma

All India Institute of Ayurveda

prajapati.pradeep1@gmail.com8368797320

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026